Atlas Trials

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Clinical trial NCT05926206 · WITHDRAWN

Trial details

NCT number
NCT05926206
Sponsor
University of Michigan Rogel Cancer Center
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Adenocarcinoma
Start date
2023-07-01
Primary completion
2027-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.